Antiviral medication to reduce symptoms of COVID-19: A phase 3, placebo-controlled trial
If you tested positive for COVID-19 within the last 5 days, you may be eligible to participate in a research study to test the ability of a pill to reduce COVID-19 symptoms.
What is the medication that is being tested?
The study medication is an antiviral pill that is designed to reduce symptoms of COVID-19
Is there payment for taking part in this study?
Participants who complete all expected parts of the study will earn $500
Am I eligible to join this study?
To find out and to learn more, please fill out the screening form below
- Study Identifier: 851173